(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

ANGIODEMAX

ArquivadaInvention Patent

Application data

Number

102013016281

Type

Invention Patent

Filing

06/25/2013

Publication

09/27/2016

Progress at the INPI

  1. Filing06/25/13
  2. Publication09/27/16
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 06/25/2013 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 05/23/2017. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

G. P. (pessoa física)

RJ, BR

Inventors

G. P. (pessoa física)

BR

S. S. (pessoa física)

BR

Technical data

Abstract

ANGIODEMAX, Patente de lnvengéo para um medicamento para 0controle do angioedema hereditario do tipi 1, constituido por um ou maisvasoconstritores, como o cloridrato de nafazolina (1), elou 0 cloridrato deoximetazolina (2) elou a catecolamina (3) capaz de reverter (anular) 0 efeitovasodilatador causado pela bradicinina originada da de?ciéncia do inibidor C1no angioedema hereditério do tipo 1

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

05/23/2017

RPI 2420

Arquivamento - Art. 33 da LPI

#11.1

03/07/2017

RPI 2409

Publicação do pedido de patente

#3.1

09/27/2016

RPI 2386

Pedido de patente depositado

#2.1

02/23/2016

RPI 2355

Requerimento de pedido de patente

#2.10

Número de Protocolo 20130055829 em 25/06/2013 11:51(RJ).

10/27/2015

RPI 2338

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.